Abstract: Selecting local gateways for VoWiFi and/or ViWiFi calls (voice traffic sessions) for a user equipment (UE) includes: receiving, by an evolved packet data gateway (ePDG), a request to initiate the voice traffic session from a WiFi router outside a cellular network that is communicatively coupled with the UE; based on at least an internet protocol (IP) address of the WiFi router or the UE, determining a geographical location of the UE; based on at least the geographical location of the UE, determining a tracking area code; based on at least the tracking area code, determining an IP address of a network gateway proximate to the UE, wherein the network gateway comprises a user plane function (UPF) and a session management function (SMF) or a packet data gateway (PGW) user plane function (PGW-U) and a PGW control plane function (PGW-C); and establishing the voice traffic session using the network gateway.

Abstract: The present invention relates to a method for preparing polyether carbonate polyols by adding alkylene oxide and carbon dioxide to a H-functional starter substance in the presence of a DMC catalyst or a metal complex catalyst based on the metals cobalt and/or zinc, wherein (?) alkylene oxide and carbon dioxide are added to a H-functional starter substance in a reactor in the presence of a DMC catalyst or a metal complex catalyst based on the metals cobalt and/or zinc, characterized in that the alkylene oxide contains a proportion of 5 to 50 wt. % ethylene oxide, based on the overall weight of the alkylene oxide used, and the addition of the ethylene oxide is carried out in an atmosphere containing carbon dioxide.

Abstract: Provided are an injectable and implantable drug delivery composition and a method for using such composition to release active ingredients and/or pharmaceutical agents to a site of action. The composition includes a gellan-gum crosslinked with L-cysteine and at least one pharmaceutical active agent in a biocompatible solvent.

Abstract: Provided are an injectable and implantable drug delivery composition and a method for using such composition to release active ingredients and/or pharmaceutical agents to a site of action. The composition includes a gellan-gum crosslinked with L-cysteine and at least one pharmaceutical active agent in a biocompatible solvent.

Abstract: Self-nanoemulsifying drug delivery system (SNEDDS) composition are provided. The compositions include at least one chemotherapeutic compound or a pharmaceutically acceptable salt thereof or mixture thereof, at least one biocompatible surfactant, wherein the at least one biocompatible surfactant includes surfactin, and at least one co-surfactant. Methods of enhancing the bioavailability of the chemotherapeutic compound and for treating cancer are also provided.

Abstract: Selecting local gateways for VoWiFi and/or ViWiFi calls (voice traffic sessions) for a user equipment (UE) includes: receiving, by an evolved packet data gateway (ePDG), a request to initiate the voice traffic session from a WiFi router outside a cellular network that is communicatively coupled with the UE; based on at least an internet protocol (IP) address of the WiFi router or the UE, determining a geographical location of the UE; based on at least the geographical location of the UE, determining a tracking area code; based on at least the tracking area code, determining an IP address of a network gateway proximate to the UE, wherein the network gateway comprises a user plane function (UPF) and a session management function (SMF) or a packet data gateway (PGW) user plane function (PGW-U) and a PGW control plane function (PGW-C); and establishing the voice traffic session using the network gateway.

Abstract: A process for making microwave-irradiated nanocomposites comprising graphene nanoplatelets dispersed in a polymer matrix, showing improved structural and electrical properties, is provided. The nanocomposites may be made using a solution casting technique, and may have a bilayer structure comprising a graphene-enriched layer in contact with a polymer-enriched layer. The nanocomposite may be used as a shielding material on electrical devices to decrease electromagnetic interference.

Abstract: A method for producing polyether ester carbonate polyols by catalytically adding alkylene oxide and carbon dioxide to an H-functional initiator substance in the presence of a double metal cyanide catalyst. The method comprises the following steps: (?) feeding a partial amount of H-functional initiator substance and/or a suspension agent which does not have any H-functional groups into a reactor, optionally together with DMC catalyst, (?) adding alkylene oxide and optionally carbon dioxide to the reactor during the reaction. The method is characterized in that in step (?) lactide is added to the reactor.

Abstract: A nanomedicine for the treatment of obesity comprising either noble metal nanoparticles having surface ligands comprising a mixture comprising (+)-catechin (2R,3S) and gingerol or particles of a carbon nanomaterial having an adsorbed mixture comprising (+)-catechin (2R,3S) and gingerol. Also provided are a method for making the noble metal nanomedicine and the carbon nanomedicine. The nanomedicine is used in a method of treating obesity.

Abstract: A nanomedicine for the treatment of obesity comprising either noble metal nanoparticles having surface ligands comprising a mixture comprising (+)-catechin (2R,3S) and gingerol or particles of a carbon nanomaterial having an adsorbed mixture comprising (+)-catechin (2R,3S) and gingerol. Also provided are a method for making the noble metal nanomedicine and the carbon nanomedicine. The nanomedicine is used in a method of treating obesity.

Abstract: A nanomedicine for the treatment of obesity comprising either noble metal nanoparticles having surface ligands comprising a mixture comprising (+)-catechin (2R,3S) and gingerol or particles of a carbon nanomaterial having an adsorbed mixture comprising (+)-catechin (2R,3S) and gingerol. Also provided are a method for making the noble metal nanomedicine and the carbon nanomedicine. The nanomedicine is used in a method of treating obesity.

Abstract: This invention relates to novel macromers containing dithiocarbonate (or xanthate) groups, novel preformed stabilizers comprising macromers, and novel polymer polyols comprising the novel macromers and/or novel preformed stabilizers. This invention also relates to processes for the preparation of these materials. Other aspects of this invention include foams comprising the novel polymer polyols and a process for preparing foam comprising the novel polymer polyols.

Abstract: A nanomedicine for the treatment of obesity comprising either noble metal nanoparticles having surface ligands comprising a mixture comprising (+)-catechin (2R,3S) and gingerol or particles of a carbon nanomaterial having an adsorbed mixture comprising (+)-catechin (2R,3S) and gingerol. Also provided are a method for making the noble metal nanomedicine and the carbon nanomedicine. The nanomedicine is used in a method of treating obesity.

Abstract: Provided herein is a process for preparing a heterocycle-functional polyoxyalkylene polyol, in which a polyoxyalkylene polyol having unsaturated groups is reacted with a heterocyclic compound. Also provided herein is a heterocycle-functional polyoxyalkylene polyol, a method of crosslinking a heterocycle-functional polyoxyalkylene polyol, a crosslinked, heterocycle-functional polyoxyalkylene polyol, and related processes.

Abstract: The present invention relates to a method for producing a prepolymer that contains carbon-carbon multiple bonds, a polyol component A) being reacted with component B) that contains isocyanate groups and the polyol component comprising a polyether carbonate polyol that contains carbon-carbon multiple bonds.

Abstract: A process for preparing a phosphorus-functional polyethercarbonate polyol, comprising reacting a polyethercarbonate polyol having unsaturated groups with a phosphorus-functional compound of formula (Ia): wherein X=O or S; and wherein R1 and R2 are selected from the group consisting of C1-C22 alkyl, C1-C22 alkoxy, C1-C22 alkylsulfanyl, C6-C70 aryl, C6-C70 aryloxy, C6-C70 arylsulfanyl, C7-C70 aralkyl, C7-C70 aralkyloxy, C7-C70 aralkylsulfanyl, C7-C70 alkylaryl, C7-C70 alkylaryloxy, C7-C70 alkylarylsulfanyl, or wherein R1 and R2 are bridged to one another directly and/or via heteroatoms and are selected from the group consisting of C1-C22 alkylene, oxygen, sulfur, and NR5, wherein R5 is hydrogen, C1-C22 alkyl, C1-C22 acyl, C7-C22 aralkyl, or C6-C70 aryl radical. A process for preparing a phosphorus-functional polyurethane polymer is disclosed.

Abstract: The present invention relates to a method for producing an organooxysilyl-crosslinked polymer by reacting a polyether carbonate polyol which contains carbon-carbon double bonds with a polysiloxane compound in the presence of a suitable catalyst. Suitable polysiloxane compounds have at least two Si—H bonds. This invention also relates to organooxysilyl-crosslinked polymers which are formed by this process.

Abstract: The present invention relates to a method for producing an organooxysilyl-crosslinked polymer by reacting a polyether carbonate polyol which contains carbon-carbon double bonds with a polysiloxane compound in the presence of a suitable catalyst. Suitable polysiloxane compounds have at least two Si—H bonds. This invention also relates to organooxysilyl-crosslinked polymers which are formed by this process.

Abstract: A process for preparing polyether thiocarbonate polyols comprising the step of reacting carbon disulfide and at least one alkylene oxide in the presence of a double metal cyanide catalyst and at least one H-functional starter compound, wherein before first contact with carbon disulfide the double metal cyanide catalyst has previously been contacted with at least one alkylene oxide the the invention likewise relates to a polyol obtainable by the process according to the invention.

Abstract: A process for preparing halogen-containing polyoxyalkylenepolyols, comprising the step of reacting an alkylene oxide with carbon dioxide in the presence of an H-functional starter compound and of a double metal cyanide catalyst, wherein the reaction is also conducted in the presence of an ?,?-epoxy-?-haloalkane.